Literature DB >> 16151432

Smoking and age-related macular degeneration: a review of association.

J Thornton1, R Edwards, P Mitchell, R A Harrison, I Buchan, S P Kelly.   

Abstract

PURPOSE: Age-related macular degeneration (AMD) is the leading cause of severe and irreversible vision loss in the Western world. As there is no effective treatment for all types of AMD, identifying modifiable risk factors is of great importance. This review evaluates the epidemiological evidence associating smoking with AMD.
METHODS: Systematic review of published epidemiological studies evaluated against established criteria for evidence of a causal relationship.
RESULTS: In total, 17 studies (cross-sectional studies, prospective cohort studies, and case-control studies) were included in the review. A total of 13 studies found a statistically significant association between smoking and AMD with increased risk of AMD of two- to three-fold in current-smokers compared with never-smokers. Five studies found no association between smoking and AMD. There was also evidence of dose-response, a temporal relationship and reversibility of effect.
CONCLUSION: The literature review confirmed a strong association between current smoking and AMD, which fulfilled established causality criteria. Cigarette smoking is likely to have toxic effects on the retina. In spite of the strength of this evidence, there appears to be a lack of awareness about the risks of developing eye disease from smoking among both healthcare professionals and the general public.

Entities:  

Mesh:

Year:  2005        PMID: 16151432     DOI: 10.1038/sj.eye.6701978

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  158 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

2.  Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction.

Authors:  Zhongbo Liu; Lijuan Sun; Lu Zhu; Xu Jia; Xuesen Li; Haiqun Jia; Ying Wang; Peter Weber; Jiangang Long; Jiankang Liu
Journal:  J Neurochem       Date:  2007-12       Impact factor: 5.372

3.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

4.  The effects of nicotine on the human electroretinogram.

Authors:  Stefanie B Varghese; Jamie C Reid; E Eugenie Hartmann; Kent T Keyser
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

Review 5.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

6.  Timely translation of ophthalmic research into clinical practice.

Authors:  C A McCarty
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

Review 7.  Age-related macular degeneration: genetics and biology coming together.

Authors:  Lars G Fritsche; Robert N Fariss; Dwight Stambolian; Gonçalo R Abecasis; Christine A Curcio; Anand Swaroop
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-16       Impact factor: 8.929

8.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

Authors:  Jie Jin Wang; Elena Rochtchina; Wayne Smith; Ronald Klein; Barbara E K Klein; Tripti Joshi; Theru A Sivakumaran; Sudha Iyengar; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

9.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

10.  Age-related macular degeneration: current treatment and future options.

Authors:  Tanya Moutray; Usha Chakravarthy
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.